Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction
about
Computational prediction of molecular pathogen-host interactions based on dual transcriptome data.Characterization of microRNA expression profiles in Leishmania-infected human phagocytes.Proteomic-based approach to gain insight into reprogramming of THP-1 cells exposed to Leishmania donovani over an early temporal window.Immunomodulatory Effects of Four Leishmania infantum Potentially Excreted/Secreted Proteins on Human Dendritic Cells Differentiation and Maturation.Differential Impact of LPG-and PG-Deficient Leishmania major Mutants on the Immune Response of Human Dendritic Cells.The TLR4 Agonist Vaccine Adjuvant, GLA-SE, Requires Canonical and Atypical Mechanisms of Action for TH1 Induction.Blood Transcriptional Profiling Reveals Immunological Signatures of Distinct States of Infection of Humans with Leishmania infantum.Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach.Protozoan Parasites and Type I IFNs.Type I interferons induced by endogenous or exogenous viral infections promote metastasis and relapse of leishmaniasis.Prospective study of the innate cellular immune response in low vaccine responder children.Irisflorentin modifies properties of mouse bone marrow-derived dendritic cells and reduces the allergic contact hypersensitivity responses.Type I Interferon Signaling Is Required for CpG-Oligodesoxynucleotide-Induced Control of Leishmania major, but Not for Spontaneous Cure of Subcutaneous Primary or Secondary L. major Infection.Inhibitor of serine peptidase 2 enhances Leishmania major survival in the skin through control of monocytes and monocyte-derived cells.
P2860
Q30897629-90AB91FF-AA88-4937-B301-29A30E3E7BA0Q34870671-510CC444-4779-4604-8E03-8880C28BEECAQ35439638-EF3C55EA-D581-431B-9905-5D813E5A0026Q35845442-0A75970C-5576-4924-AF3B-D1EC067185A2Q35859111-ADACE3FD-AC7B-47C9-B4D4-4469CC43CF13Q35885464-BFD80352-A0A2-42F0-8DC3-64F835EB34A3Q36187247-2FF3FB04-EA5B-4405-9223-2225C9C457D4Q36339132-1EBF26A4-4BD8-421E-BF64-44FAC709680CQ37592659-6F7B9C46-B637-4818-8C11-C3CB066A085BQ40229581-12902FD1-ECA0-4D14-8A72-6CC6D5911E47Q40444652-8377C9C4-D058-4888-BC90-EA22D7B2F09AQ47439674-0B81B720-B8DA-402E-88BD-A0EC756B17ADQ49829392-A5B3B7A0-935D-40C3-864C-15A745FD44C3Q52818211-A1738449-7AEE-43F2-8134-86499BA2157A
P2860
Human dendritic cells exhibit a pronounced type I IFN signature following Leishmania major infection that is required for IL-12 induction
description
2014 nî lūn-bûn
@nan
2014 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Human dendritic cells exhibit ...... s required for IL-12 induction
@ast
Human dendritic cells exhibit ...... s required for IL-12 induction
@en
type
label
Human dendritic cells exhibit ...... s required for IL-12 induction
@ast
Human dendritic cells exhibit ...... s required for IL-12 induction
@en
prefLabel
Human dendritic cells exhibit ...... s required for IL-12 induction
@ast
Human dendritic cells exhibit ...... s required for IL-12 induction
@en
P2093
P2860
P50
P356
P1476
Human dendritic cells exhibit ...... s required for IL-12 induction
@en
P2093
Asha Jayakumar
Brent Harker
Mary Ann McDowell
Michelle A Favila
Vinita Tripathi
P2860
P304
P356
10.4049/JIMMUNOL.1203230
P407
P577
2014-05-07T00:00:00Z